Abstract
Two male patients with achondroplastic dwarfism aged 7-5/12 and 14½ years were treated with human growth hormone 5 mg daily. Both showed nitrogen retention on balance studies, the older second patient to a marked degree. In the younger patient, height increased from 95.4 to 106.3 cm on hgh 5 mg daily alone for 14 out of 24 months. The rate of growth approximately doubled during the first two treatment periods as compared with the pre-treatment rate. In the second older patient hgh was administered 5 mg daily intramuscularly for 21 out of 33 months. Growth from 129.6 cm to 137.8 cm occurred with the rate increasing following the addition of Na-1-thyroxine to the routine. This increased growth rate occurred during the post-puberty deceleration phase. Bone ages, interpreted from changes in the phalanges and metacarpals, increased from 4½ to 6 years during 16 months in Case 1, and from 13½ to 18 years in 33 months in Case 2. Transient adolescent gynecomastia appeared in Case 2. No local or general toxic effects were noted.
These results are suggestive, but whether or not the eventual height of an achondroplastic dwarf can be significantly altered must await further studies.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- COLE R. D., LI C. H. Studies on pituitary lactogenic hormone. XIV. A simplified procedure of isolation. J Biol Chem. 1955 Mar;213(1):197–201. [PubMed] [Google Scholar]
- ESCAMILLA R. F., BENNETT L. Pituitary infantilism treated with purified growth hormone, thyroid, and sublingual methyltestosterone; a case report. J Clin Endocrinol Metab. 1951 Feb;11(2):221–228. doi: 10.1210/jcem-11-2-221. [DOI] [PubMed] [Google Scholar]
- ESCAMILLA R. F., HUTCHINGS J. J., DEAMER W. C., LI C. H., FORSHAM P. H. Long-term effects of human growth hormone (Li) in a pituitary dwarf. J Clin Endocrinol Metab. 1961 Jun;21:721–726. doi: 10.1210/jcem-21-6-721. [DOI] [PubMed] [Google Scholar]
- HUTCHINGS J. J., ESCAMILLA R. F., DEAMER W. C., LI C. H. Metabolic changes produced by human growth hormone (Li) in a pituitary dwarf. J Clin Endocrinol Metab. 1959 Jul;19(7):759–769. doi: 10.1210/jcem-19-7-759. [DOI] [PubMed] [Google Scholar]
- HUTCHINGS J. J., ESCAMILLA R. F., LI C. H., FORSHAM P. H. LI HUMAN GROWTH HORMONE ADMINISTRATION IN GONADAL DYSGENESIS. Am J Dis Child. 1965 Apr;109:318–321. doi: 10.1001/archpedi.1965.02090020320010. [DOI] [PubMed] [Google Scholar]
- LI C. H., PAPKOFF H., HAYASHIDA T. Preparation and properties of beef alpha-core from chymotrypic digestion of bovine growth hormone. Arch Biochem Biophys. 1959 Nov;85:97–102. doi: 10.1016/0003-9861(59)90452-7. [DOI] [PubMed] [Google Scholar]
- LI C. H., PAPKOFF H. Preparation and properties of growth hormone from human and monkey pituitary glands. Science. 1956 Dec 28;124(3235):1293–1294. doi: 10.1126/science.124.3235.1293. [DOI] [PubMed] [Google Scholar]
- WHITELAW M. J., THOMAS S. F., GRAHAM W. H., JENNSON M. H. [Steroid treatment of achondroplasia. The effect of 17-ethyl-19-nortestosterone (Nilevar) with report on a clinical case]. Dtsch Med Wochenschr. 1961 Nov 10;86:2159–2162. doi: 10.1055/s-0028-1113067. [DOI] [PubMed] [Google Scholar]